News FocusBIOMEDICAL SCIENCE

Can Money Turn Singapore Into a Biotech Juggernaut?

See allHide authors and affiliations

Science  30 Aug 2002:
Vol. 297, Issue 5586, pp. 1470-1473
DOI: 10.1126/science.297.5586.1470

You are currently viewing the summary.

View Full Text

Summary

SINGAPORE-- Singapore is betting that a $2 billion initiative will create the talent pool and business climate needed for a world-class biomedical enterprise. The city-state will need to attract enough rank-and-file life science researchers to achieve a critical mass, and then it will need to keep them long enough to have an impact. But the gamble has already started to pay off.